Dipòsit Digital de Documents de la UAB 35 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.00 segons. 
1.
10 p, 852.9 KB El estigma de la obesidad y su impacto en la salud : una revisión narrativa / Sánchez Carracedo, David (Universitat Autònoma de Barcelona)
El estigma de la obesidad está generalizado en nuestra sociedad, y se basa en la suposición errónea de que la obesidad se deriva principalmente de una falta de autodisciplina y responsabilidad personal, obviando la evidencia reciente que muestra que la obesidad es una enfermedad crónica prevalente, compleja, progresiva y recidivante, que resulta de la interacción entre factores conductuales, medioambientales, genéticos y metabólicos. [...]
Weight stigma and weight bias are pervasive in our society and are based on wrong assumption that obesity derives basically from a lack self-discipline and personal responsibility, obviating recent evidence showing that obesity is a prevalent, complex, progressive, and relapsing chronic disease that results from the interaction between behavioural, environmental, genetic, and metabolic factors. [...]

Elsevier, 2022 - 10.1016/j.endinu.2021.12.002
Endocrinologia, Diabetes y Nutricion  
2.
14 p, 455.4 KB Cost Analysis of FreeStyle Libre ® 2 System in Type 2 Diabetes Mellitus Population / Oyagüez, Itziar (Pharmacoeconomics and Outcomes Research Iberia (PORIB)) ; Gómez-Peralta, Fernando (Hospital General de Segovia) ; Artola, Sara (Centro de Salud José Marvá, Madrid) ; Carrasco, Francisco J. (Universitat de Girona) ; Carretero-Gómez, Juana (Hospital de Zafra, Badajoz) ; García-Soidan, Javier (Centro de Saúde do Porriño) ; Gómez-Huelgas, Ricardo (Hospital Regional Universitario de Málaga) ; Merino-Torres, Juan F. (Hospital Universitari i Politècnic La Fe de València) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
FreeStyle Libre ® 2 system is a sensor-based flash-monitoring system that measures interstitial fluid glucose. The study aimed to compare cost of FreeStyle Libre 2 system and self-monitoring of blood glucose (SMBG) in the type 2 diabetes mellitus (T2DM) population from the Spanish Health System perspective. [...]
2021 - 10.1007/s13300-021-01064-4
Diabetes Therapy, may 2021, p. 1-14  
3.
12 p, 1.0 MB Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy / Guillén-Gómez, Elena (Institut d'Investigació Biomèdica Sant Pau) ; Bardají de Quixano, Beatriz (Institut d'Investigació Biomèdica Sant Pau) ; Ferrer, Sílvia (Centre d'Atenció Primària (CAP) Passeig de Maragall, Barcelona) ; Brotons, Carlos (Equip d'Atenció Primària Barcelona Sardenya, Barcelona) ; Knepper, Mark A. (National Heart, Lung, and Blood Institute (NIH), Bethesda, MD, USA) ; Carrascal Pérez, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Abian, Joaquin (Institut d'Investigació Biomèdica Sant Pau) ; Mas, José M. (Anaxomics Biotech SL) ; Calero, Francesca (Institut d'Investigació Biomèdica Sant Pau) ; Ballarín Castan, José Aurelio (Institut d'Investigació Biomèdica Sant Pau) ; Fernandez-Llama, Patricia (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Urinary proteome was analyzed and quantified by tandem mass tag (TMT) labeling followed by bioinformatics analysis to study diabetic nephropathy (DN) pathophysiology and to identify biomarkers of a clinical outcome. [...]
2018 - 10.1155/2018/6165303
Journal of Diabetes Research, Vol. 2018 (april 2018)  
4.
10 p, 577.9 KB Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes : results of the phase IV COBALTA trial / Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Carrasco-Sánchez, Francisco Javier (Hospital Juan Ramón Jiménez (Huelva)) ; González, Carlos (Hospital Universitario 12 de Octubre (Madrid)) ; Seguí-Ripoll, José Miguel (Hospital Universitario San Joan d'Alacant) ; Trescolí, Carlos (Hospital Universitario de La Ribera) ; Ena, Javier (Hospital Marina Baixa (La Vila Joiosa, Alacant)) ; Borrell, Mireia (Sanofi) ; Gomez Huelgas, Ricardo (Instituto de Investigación Biomédica de Málaga) ; Universitat Autònoma de Barcelona
This study assessed the efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in insufficiently controlled people with type 2 diabetes. [...]
2020 - 10.1136/bmjdrc-2020-001518
BMJ open diabetes research and care, Vol. 8 (september 2020)  
5.
2 p, 175.3 KB Correction to : Cost Analysis of FreeStyle Libre ® 2 System in Type 2 Diabetes Mellitus Population / Oyagüez, Itziar (Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 - letra I, Pozuelo de Alarcón, 28224 Madrid, Spain) ; Gómez-Peralta, Fernando (Hospital General de Segovia) ; Artola, Sara (Centro de Salud José Marvá, Madrid) ; Carrasco, Francisco J. (Hospital Juan Ramón Jiménez (Huelva)) ; Carretero-Gómez, Juana (Hospital de Zafra, Badajoz) ; García-Soidan, Javier (Servicio atención primaria de o Porriño) ; Gómez-Huelgas, Ricardo (Hospital Regional Universitario de Málaga) ; Merino-Torres, Juan F. (Hospital Universitari i Politècnic La Fe de València) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
2021 - 10.1007/s13300-021-01093-z
Diabetes Therapy, Vol. 12 (july 2021) , p. 2263-2264  
6.
12 p, 346.6 KB Inpatient Hyperglycemia Management and COVID-19 / Bellido, Virginia (University of the Basque Country (UPV/EHU)) ; Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been associated with worse outcomes, so it is mandatory to implement effective glycemic control treatment approaches for inpatients with COVID-19. [...]
2020 - 10.1007/s13300-020-00966-z
Diabetes Therapy, december 2020, p. 1-12  
7.
15 p, 1.1 MB Impact of Intensive Glucose Control on Brain Health : Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus / Tang, Xingyao (Capital Medical University. Beijing Tongren Hospital) ; Cardoso, Marly A. (University of Sao Paulo. Department of Nutrition, School of Public Health) ; Yang, Jinkui (Capital Medical University. Department of Endocrinology, Beijing Tongren Hospital) ; Zhou, Jian-Bo (Capital Medical University. Department of Endocrinology, Beijing Tongren Hospital) ; Simó Canonge, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina)
Despite growing evidence that type 2 diabetes is associated with dementia, the question of whether intensive glucose control can prevent or arrest cognitive decline remains unanswered. In the analysis reported here, we explored the effect of intensive glucose control versus standard care on brain health, including structural abnormalities of the brain (atrophy, white matter hyperintensities, lacunar infarction, and cerebral microbleeds), cognitive dysfunction, and risk of dementia. [...]
2021 - 10.1007/s13300-021-01009-x
Diabetes Therapy, Vol. 12 (february 2021) , p. 765-779  
8.
18 p, 767.0 KB Neuroprotection as a Therapeutic Target for Diabetic Retinopathy / Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Dal Monte, Massimo (Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health", University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Casini, Giovanni (Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health", University of Pisa, Via del Borghetto 80, 56124 Pisa, Italy) ; Universitat Autònoma de Barcelona
Diabetic retinopathy (DR) is a multifactorial progressive disease of the retina and a leading cause of vision loss. DR has long been regarded as a vascular disorder, although neuronal death and visual impairment appear before vascular lesions, suggesting an important role played by neurodegeneration in DR and the appropriateness of neuroprotective strategies. [...]
2016 - 10.1155/2016/9508541
Journal of Diabetes Research, Vol. 2016 (march 2016)  
9.
5 p, 396.1 KB Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia / Sampedro, Frederic (Institut d'Investigació Biomèdica Sant Pau) ; Stantonyonge, Nicole (Institut d'Investigació Biomèdica Sant Pau) ; Martínez-Horta, Saül (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Muñoz, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Pérez-González, Rocío (Institut d'Investigació Biomèdica Sant Pau) ; Marín-Lahoz, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Gómez Ansón, Beatriz (Institut d'Investigació Biomèdica Sant Pau) ; Chico Ballesteros, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Impaired awareness of hypoglycemia (IAH) is a common complication in patients with type-1 diabetes (T1D). IAH is a major risk factor for severe hypoglycemic events, leading to adverse clinical consequences and cerebral damage. [...]
2020 - 10.1136/bmjdrc-2020-001516
BMJ open diabetes research and care, Vol. 8 (july 2020)  
10.
8 p, 276.2 KB Key factors for overcoming psychological insulin resistance : an examination of patient perspectives through content analysis / Stuckey, Heather (Pennsylvania State University) ; Fisher, Lawrence (University of California, San Francisco) ; Polonsky, William H (University of California, San Diego) ; Hessler, Danielle (University of California San Francisco) ; Snoek, Frank J (Amsterdam University Medical Centre) ; Tang, Tricia S (University of British Columbia) ; Hermanns, Norbert (Diabet Acad Mergentheim FIDAM) ; Mundet-Tudurí, Xavier (Universitat Autònoma de Barcelona) ; da Silva, Maria Elizabeth Rossi (Hospital das Clínicas da Faculdade de Medicina da USP) ; Sturt, Jackie (King's College London) ; Okazaki, Kentaro (Nagoya University Graduate School of Medicine) ; Cao, Dachuang (Eli Lilly and Company) ; Hadjiyianni, Irene (Lilly Deutschland GmbH) ; Ivanova, Jasmina I (Analysis Group Inc Boston) ; Desai, Urvi (Analysis Group Inc Boston) ; Perez-Nieves, Magaly (Eli Lilly and Company)
To understand participant perceptions about insulin and identify key behaviors of healthcare professionals (HCPs) that motivated initially reluctant adults from seven countries (n=40) who had type 2 diabetes (T2D) to start insulin treatment. [...]
2019 - 10.1136/bmjdrc-2019-000723
BMJ open diabetes research and care, Vol. 7 (december 2019)  

Dipòsit Digital de Documents de la UAB : 35 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.